- Home
- ARMP vs GRWG Comparison
ARMP vs GRWG Comparison
Compare ARMP & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- GRWG
- Stock Information
- Founded
- ARMP N/A
- GRWG 2008
- Country
- ARMP United States
- GRWG United States
- Employees
- ARMP N/A
- GRWG N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- GRWG RETAIL: Building Materials
- Sector
- ARMP Health Care
- GRWG Consumer Discretionary
- Exchange
- ARMP Nasdaq
- GRWG Nasdaq
- Market Cap
- ARMP 52.1M
- GRWG 60.6M
- IPO Year
- ARMP N/A
- GRWG N/A
- Fundamental
- Price
- ARMP $1.95
- GRWG $1.08
- Analyst Decision
- ARMP Strong Buy
- GRWG Buy
- Analyst Count
- ARMP 1
- GRWG 4
- Target Price
- ARMP $9.00
- GRWG $2.38
- AVG Volume (30 Days)
- ARMP 624.1K
- GRWG 461.2K
- Earning Date
- ARMP 05-14-2025
- GRWG 05-08-2025
- Dividend Yield
- ARMP N/A
- GRWG N/A
- EPS Growth
- ARMP N/A
- GRWG N/A
- EPS
- ARMP N/A
- GRWG N/A
- Revenue
- ARMP $4,699,000.00
- GRWG $176,681,000.00
- Revenue This Year
- ARMP $8.43
- GRWG N/A
- Revenue Next Year
- ARMP N/A
- GRWG $0.26
- P/E Ratio
- ARMP N/A
- GRWG N/A
- Revenue Growth
- ARMP 14.24
- GRWG N/A
- 52 Week Low
- ARMP $0.90
- GRWG $0.82
- 52 Week High
- ARMP $3.42
- GRWG $2.73
- Technical
- Relative Strength Index (RSI)
- ARMP 56.79
- GRWG 48.06
- Support Level
- ARMP $1.74
- GRWG $1.05
- Resistance Level
- ARMP $2.20
- GRWG $1.16
- Average True Range (ATR)
- ARMP 0.32
- GRWG 0.06
- MACD
- ARMP 0.04
- GRWG -0.01
- Stochastic Oscillator
- ARMP 50.32
- GRWG 23.08
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.